These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
¨
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Maryland
|
|
27-0467113
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Assets:
|
|
|
|
||||
|
Cash
|
$
|
98,310
|
|
|
$
|
77,671
|
|
|
Commercial mortgage loans, net (includes $2,176,126 and $2,148,368 pledged as collateral under secured debt arrangements in 2018 and 2017, respectively)
|
3,029,240
|
|
|
2,653,826
|
|
||
|
Subordinate loans, net
|
1,038,254
|
|
|
1,025,932
|
|
||
|
Loan proceeds held by servicer
|
30,281
|
|
|
302,756
|
|
||
|
Other assets
|
46,087
|
|
|
28,420
|
|
||
|
Total Assets
|
$
|
4,242,172
|
|
|
$
|
4,088,605
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Secured debt arrangements, net (net of deferred financing costs of $14,037 and $14,348 in 2018 and 2017, respectively)
|
$
|
1,212,749
|
|
|
$
|
1,330,847
|
|
|
Convertible senior notes, net
|
585,972
|
|
|
584,897
|
|
||
|
Derivative liabilities, net
|
14,499
|
|
|
5,644
|
|
||
|
Accounts payable, accrued expenses and other liabilities
|
73,330
|
|
|
70,906
|
|
||
|
Payable to related party
|
8,092
|
|
|
8,168
|
|
||
|
Total Liabilities
|
1,894,642
|
|
|
2,000,462
|
|
||
|
Commitments and Contingencies (see Note 15)
|
|
|
|
|
|
||
|
Stockholders’ Equity:
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 shares authorized:
|
|
|
|
||||
|
Series B preferred stock, 6,770,393 shares issued and outstanding ($169,260 aggregate liquidation preference) in 2018 and 2017
|
68
|
|
|
68
|
|
||
|
Series C preferred stock, 6,900,000 shares issued and outstanding ($172,500 aggregate liquidation preference) in 2018 and 2017
|
69
|
|
|
69
|
|
||
|
Common stock, $0.01 par value, 450,000,000 shares authorized, 122,992,231 and 107,121,235 shares issued and outstanding in 2018 and 2017, respectively
|
1,230
|
|
|
1,071
|
|
||
|
Additional paid-in-capital
|
2,444,036
|
|
|
2,170,078
|
|
||
|
Accumulated deficit
|
(97,873
|
)
|
|
(83,143
|
)
|
||
|
Total Stockholders’ Equity
|
2,347,530
|
|
|
2,088,143
|
|
||
|
Total Liabilities and Stockholders’ Equity
|
$
|
4,242,172
|
|
|
$
|
4,088,605
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net interest income:
|
|
|
|
||||
|
Interest income from commercial mortgage loans
|
$
|
52,114
|
|
|
$
|
34,398
|
|
|
Interest income from subordinate loans
|
33,853
|
|
|
34,390
|
|
||
|
Interest income from securities
|
—
|
|
|
6,054
|
|
||
|
Interest expense
|
(22,740
|
)
|
|
(17,030
|
)
|
||
|
Net interest income
|
63,227
|
|
|
57,812
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
General and administrative expenses (includes equity-based compensation of $3,342 and $3,791 in 2018 and 2017, respectively)
|
(4,998
|
)
|
|
(5,758
|
)
|
||
|
Management fees to related party
|
(8,092
|
)
|
|
(7,432
|
)
|
||
|
Total operating expenses
|
(13,090
|
)
|
|
(13,190
|
)
|
||
|
Income from unconsolidated joint venture
|
—
|
|
|
458
|
|
||
|
Other income
|
203
|
|
|
108
|
|
||
|
Realized loss on sale of assets
|
—
|
|
|
(1,042
|
)
|
||
|
Unrealized gain on securities
|
—
|
|
|
2,852
|
|
||
|
Foreign currency gain
|
10,125
|
|
|
3,172
|
|
||
|
Loss on derivative instruments (includes unrealized losses of $(8,855) and $(2,889) in 2018 and 2017, respectively)
|
(11,032
|
)
|
|
(3,045
|
)
|
||
|
Net income
|
49,433
|
|
|
47,125
|
|
||
|
Preferred dividends
|
$
|
(6,835
|
)
|
|
$
|
(9,310
|
)
|
|
Net income available to common stockholders
|
42,598
|
|
|
37,815
|
|
||
|
Net income per share of common stock
|
$
|
0.38
|
|
|
$
|
0.41
|
|
|
Basic weighted average shares of common stock outstanding
|
110,211,853
|
|
|
91,612,447
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
111,871,429
|
|
|
92,998,250
|
|
||
|
Dividend declared per share of common stock
|
$
|
0.46
|
|
|
$
|
0.46
|
|
|
|
Three months ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net income available to common stockholders
|
$
|
42,598
|
|
|
$
|
37,815
|
|
|
Foreign currency translation adjustment
|
—
|
|
|
251
|
|
||
|
Comprehensive income
|
$
|
42,598
|
|
|
$
|
38,066
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-In-Capital
|
|
Accumulated
Deficit
|
|
Total
|
||||||||||||||||
|
|
Shares
|
|
Par
|
|
Shares
|
|
Par
|
|
|||||||||||||||||
|
Balance at January 1, 2018
|
13,670,393
|
|
|
$
|
137
|
|
|
107,121,235
|
|
|
$
|
1,071
|
|
|
$
|
2,170,078
|
|
|
$
|
(83,143
|
)
|
|
$
|
2,088,143
|
|
|
Capital increase (decrease) related to Equity Incentive Plan
|
—
|
|
|
—
|
|
|
345,996
|
|
|
4
|
|
|
(1,389
|
)
|
|
—
|
|
|
(1,385
|
)
|
|||||
|
Issuance of common stock
|
—
|
|
|
—
|
|
|
15,525,000
|
|
|
155
|
|
|
275,724
|
|
|
—
|
|
|
275,879
|
|
|||||
|
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(377
|
)
|
|
—
|
|
|
(377
|
)
|
|||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
49,433
|
|
|
49,433
|
|
|||||
|
Dividends declared on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,835
|
)
|
|
(6,835
|
)
|
|||||
|
Dividends declared on common stock - $0.46 per share
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(57,328
|
)
|
|
(57,328
|
)
|
|||||
|
Balance at March 31, 2018
|
13,670,393
|
|
$
|
137
|
|
|
122,992,231
|
|
$
|
1,230
|
|
|
$
|
2,444,036
|
|
|
$
|
(97,873
|
)
|
|
$
|
2,347,530
|
|
||
|
|
For the three months ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Cash flows (used in) provided by operating activities:
|
|
|
|
||||
|
Net income
|
$
|
49,433
|
|
|
$
|
47,125
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Amortization of discount/premium and PIK
|
(15,695
|
)
|
|
(3,517
|
)
|
||
|
Amortization of deferred financing costs
|
2,545
|
|
|
1,203
|
|
||
|
Equity-based compensation
|
(1,385
|
)
|
|
1,461
|
|
||
|
Unrealized gain on securities
|
—
|
|
|
(2,852
|
)
|
||
|
Income from unconsolidated joint venture
|
—
|
|
|
(458
|
)
|
||
|
Foreign currency gain
|
(9,853
|
)
|
|
(2,808
|
)
|
||
|
Unrealized loss on derivative instruments
|
8,855
|
|
|
2,897
|
|
||
|
Realized loss on sale of assets
|
—
|
|
|
1,042
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Proceeds received from PIK
|
55,000
|
|
|
—
|
|
||
|
Other assets
|
(2,620
|
)
|
|
(10,926
|
)
|
||
|
Accounts payable, accrued expenses and other liabilities
|
2,075
|
|
|
(8,011
|
)
|
||
|
Payable to related party
|
(76
|
)
|
|
418
|
|
||
|
Net cash (used in) provided by operating activities
|
88,279
|
|
|
25,574
|
|
||
|
Cash flows used in investing activities:
|
|
|
|
||||
|
New funding of commercial mortgage loans
|
(476,951
|
)
|
|
(258,950
|
)
|
||
|
Add-on funding of commercial mortgage loans
|
(13,185
|
)
|
|
(60,649
|
)
|
||
|
New funding of subordinate loans
|
(11,687
|
)
|
|
(117,500
|
)
|
||
|
Add-on funding of subordinate loans
|
(5,208
|
)
|
|
(55,182
|
)
|
||
|
Payments received on commercial mortgage loans
|
90,547
|
|
|
6,336
|
|
||
|
Payments received on subordinate loans
|
257,548
|
|
|
37,738
|
|
||
|
Origination and exit fees received on commercial mortgage and subordinate loans
|
19,085
|
|
|
6,294
|
|
||
|
Funding of unconsolidated joint venture
|
—
|
|
|
(726
|
)
|
||
|
Funding of other assets
|
—
|
|
|
(1,379
|
)
|
||
|
Increase in collateral held related to derivative contracts
|
(15,220
|
)
|
|
(960
|
)
|
||
|
Payments and proceeds received on securities
|
—
|
|
|
70,033
|
|
||
|
Net cash (used in) provided by investing activities
|
(155,071
|
)
|
|
(374,945
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Proceeds from issuance of common stock
|
275,879
|
|
|
—
|
|
||
|
Payment of offering costs
|
(38
|
)
|
|
(58
|
)
|
||
|
Proceeds from secured debt arrangements
|
416,549
|
|
|
407,955
|
|
||
|
Repayments of secured debt arrangements
|
(538,562
|
)
|
|
(67,286
|
)
|
||
|
Repayments of participations sold
|
—
|
|
|
(434
|
)
|
||
|
Payment of deferred financing costs
|
(2,234
|
)
|
|
(4,394
|
)
|
||
|
Dividends on common stock
|
(57,328
|
)
|
|
(42,947
|
)
|
||
|
Dividends on preferred stock
|
(6,835
|
)
|
|
(9,310
|
)
|
||
|
Net cash (used in) provided by financing activities
|
87,431
|
|
|
283,526
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
20,639
|
|
|
(65,845
|
)
|
||
|
Cash and restricted cash, beginning of period
|
77,671
|
|
|
263,452
|
|
||
|
Cash and restricted cash, end of period
|
$
|
98,310
|
|
|
$
|
197,607
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Interest paid
|
$
|
26,517
|
|
|
$
|
18,965
|
|
|
Supplemental disclosure of non-cash financing activities:
|
|
|
|
||||
|
Dividend declared, not yet paid
|
$
|
63,598
|
|
|
$
|
51,109
|
|
|
Offering costs payable
|
$
|
339
|
|
|
$
|
222
|
|
|
Loan proceeds held by servicer
|
$
|
30,281
|
|
|
$
|
—
|
|
|
|
Balance at March 31, 2018
|
|
Balance at March 31, 2017
|
||||
|
Cash
|
$
|
98,310
|
|
|
$
|
142,905
|
|
|
Restricted cash
|
$
|
—
|
|
|
$
|
54,702
|
|
|
Total cash and restricted cash shown in the condensed consolidated statement of cash flows
|
$
|
98,310
|
|
|
$
|
197,607
|
|
|
|
Fair Value as of March 31, 2018
|
|
Fair Value as of December 31, 2017
|
||||||||||||||||||||||||||||
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||||||||||
|
Derivative instruments, net
|
$
|
—
|
|
|
$
|
(14,499
|
)
|
|
$
|
—
|
|
|
$
|
(14,499
|
)
|
|
$
|
—
|
|
|
$
|
(5,644
|
)
|
|
$
|
—
|
|
|
$
|
(5,644
|
)
|
|
Loan Type
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Commercial mortgage loans, net
|
|
$
|
3,029,240
|
|
|
$
|
2,653,826
|
|
|
Subordinate loans, net
|
|
1,038,254
|
|
|
1,025,932
|
|
||
|
Total loans, net
|
|
$
|
4,067,494
|
|
|
$
|
3,679,758
|
|
|
|
|
Principal Balance
|
|
Deferred Fees/Other Items
(1)
|
|
Provision for Loan Loss
(2)
|
|
Carrying Value
|
||||||||
|
December 31, 2017
|
|
$
|
3,706,169
|
|
|
$
|
(9,430
|
)
|
|
$
|
(16,981
|
)
|
|
$
|
3,679,758
|
|
|
New loan fundings
|
|
488,638
|
|
|
—
|
|
|
—
|
|
|
488,638
|
|
||||
|
Add-on loan fundings
|
|
18,393
|
|
|
—
|
|
|
—
|
|
|
18,393
|
|
||||
|
Loan repayments
|
|
(137,947
|
)
|
|
—
|
|
|
—
|
|
|
(137,947
|
)
|
||||
|
Unrealized gain (loss) on foreign currency translation
|
|
13,555
|
|
|
(113
|
)
|
|
—
|
|
|
13,442
|
|
||||
|
Deferred fees and other items
(1)
|
|
—
|
|
|
(11,561
|
)
|
|
—
|
|
|
(11,561
|
)
|
||||
|
PIK interest, amortization of fees and other items
(1)
|
|
10,564
|
|
|
6,207
|
|
|
—
|
|
|
16,771
|
|
||||
|
March 31, 2018
|
|
$
|
4,099,372
|
|
|
$
|
(14,897
|
)
|
|
$
|
(16,981
|
)
|
|
$
|
4,067,494
|
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Number of loans
|
|
63
|
|
|
59
|
|
||
|
Principal balance
|
|
$
|
4,099,372
|
|
|
$
|
3,706,169
|
|
|
Carrying value
|
|
$
|
4,067,494
|
|
|
$
|
3,679,758
|
|
|
Unfunded loan commitments
(1)
|
|
$
|
852,508
|
|
|
$
|
435,627
|
|
|
Weighted-average cash coupon
(2)
|
|
8.6
|
%
|
|
8.4
|
%
|
||
|
(1)
|
Unfunded loan commitments are primarily funded to finance property improvements or lease-related expenditures by the borrowers. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.
|
|
(2)
|
For floating rate loans, based on applicable benchmark rates as of the specified dates.
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Property Type
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
|
Predevelopment
|
|
$710,992
|
|
17.5%
|
|
$654,736
|
|
17.8%
|
|
Residential - for sale
|
|
704,020
|
|
17.3%
|
|
442,177
|
|
12.0%
|
|
Hotel
|
|
654,631
|
|
16.1%
|
|
645,056
|
|
17.6%
|
|
Office
|
|
584,990
|
|
14.4%
|
|
513,830
|
|
14.0%
|
|
Residential Rental
|
|
467,605
|
|
11.5%
|
|
465,057
|
|
12.6%
|
|
Mixed Use
|
|
356,079
|
|
8.7%
|
|
354,640
|
|
9.6%
|
|
Retail Center
|
|
199,463
|
|
4.9%
|
|
198,913
|
|
5.4%
|
|
Healthcare
|
|
158,292
|
|
3.9%
|
|
173,870
|
|
4.7%
|
|
Other
|
|
154,084
|
|
3.8%
|
|
154,141
|
|
4.2%
|
|
Industrial
|
|
77,338
|
|
1.9%
|
|
77,338
|
|
2.1%
|
|
|
|
$4,067,494
|
|
100.0%
|
|
$3,679,758
|
|
100.0%
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Geographic Location
|
|
Carrying
Value |
|
% of
Portfolio |
|
Carrying
Value |
|
% of
Portfolio |
|
Manhattan, NY
|
|
$1,209,678
|
|
29.7%
|
|
$1,173,833
|
|
31.9%
|
|
Brooklyn, NY
|
|
358,425
|
|
8.8%
|
|
357,611
|
|
9.7%
|
|
Northeast
|
|
107,671
|
|
2.7%
|
|
100,536
|
|
2.7%
|
|
Midwest
|
|
737,780
|
|
18.1%
|
|
683,380
|
|
18.6%
|
|
Southeast
|
|
447,450
|
|
11.0%
|
|
531,582
|
|
14.4%
|
|
West
|
|
270,170
|
|
6.6%
|
|
227,024
|
|
6.2%
|
|
Mid Atlantic
|
|
182,320
|
|
4.5%
|
|
191,976
|
|
5.2%
|
|
Southwest
|
|
33,384
|
|
0.8%
|
|
33,615
|
|
0.9%
|
|
United Kingdom
|
|
645,338
|
|
15.9%
|
|
303,488
|
|
8.3%
|
|
Other International
|
|
75,278
|
|
1.9%
|
|
76,713
|
|
2.1%
|
|
Total
|
|
$4,067,494
|
|
100.0%
|
|
$3,679,758
|
|
100.0%
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||
|
Risk Rating
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
|
Number of Loans
|
|
Carrying Value
|
|
% of Loan Portfolio
|
||||||
|
1
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
|
—
|
|
$
|
—
|
|
|
—
|
%
|
|
2
|
|
6
|
|
395,212
|
|
|
10
|
%
|
|
5
|
|
399,326
|
|
|
10
|
%
|
||
|
3
|
|
54
|
|
3,431,086
|
|
|
84
|
%
|
|
51
|
|
3,034,358
|
|
|
83
|
%
|
||
|
4
|
|
1
|
|
168,677
|
|
|
4
|
%
|
|
1
|
|
168,208
|
|
|
5
|
%
|
||
|
5
|
|
2
|
|
72,519
|
|
|
2
|
%
|
|
2
|
|
77,866
|
|
|
2
|
%
|
||
|
|
|
63
|
|
$
|
4,067,494
|
|
|
100
|
%
|
|
59
|
|
$
|
3,679,758
|
|
|
100
|
%
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Interest receivable
|
$
|
25,548
|
|
|
$
|
23,101
|
|
|
Collateral deposited under derivative agreements
|
20,150
|
|
|
4,930
|
|
||
|
Other
|
389
|
|
|
389
|
|
||
|
Total
|
$
|
46,087
|
|
|
$
|
28,420
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity
(1)
|
|
Weighted
Average Rate (2) |
|
Maximum Amount of Borrowings
|
|
Borrowings Outstanding
|
|
Maturity
(1)
|
|
Weighted
Average Rate (2) |
||||||||
|
JPMorgan Facility
(3)
|
$
|
1,382,000
|
|
|
$
|
800,535
|
|
|
March 2020
|
|
USD L + 2.30%
|
|
$
|
1,393,000
|
|
|
$
|
944,529
|
|
|
March 2020
|
|
USD L + 2.30%
|
|
DB Repurchase Facility (USD)
(4)
|
402,390
|
|
|
157,460
|
|
|
March 2020
|
|
USD L + 2.48%
|
|
472,090
|
|
|
225,367
|
|
|
March 2020
|
|
USD L + 2.56%
|
||||
|
DB Repurchase Facility (GBP)
(4)
|
165,766
|
|
|
165,766
|
|
|
March 2020
|
|
GBP L + 2.60%
|
|
93,919
|
|
|
93,919
|
|
|
March 2020
|
|
GBP L + 2.60%
|
||||
|
Goldman Facility
(5)
|
327,750
|
|
|
103,025
|
|
|
November 2020
|
|
USD L + 2.57%
|
|
331,130
|
|
|
81,380
|
|
|
November 2020
|
|
USD L + 2.73%
|
||||
|
Sub-total
|
2,277,906
|
|
|
1,226,786
|
|
|
|
|
|
|
2,290,139
|
|
|
1,345,195
|
|
|
|
|
|
||||
|
less: deferred financing costs
|
N/A
|
|
|
(14,037
|
)
|
|
|
|
N/A
|
|
N/A
|
|
|
(14,348
|
)
|
|
|
|
N/A
|
||||
|
Total / Weighted Average
|
$
|
2,277,906
|
|
|
$
|
1,212,749
|
|
|
|
|
USD L + 2.35% /
|
|
$
|
2,290,139
|
|
|
$
|
1,330,847
|
|
|
|
|
USD L + 2.37% /
|
|
|
|
GBP L + 2.60%
|
|
|
|
|
GBP L + 2.60%
|
||||||||||||||||
|
|
Less than
1 year (1) |
|
1 to 3
years (1) |
|
3 to 5
years |
|
More than
5 years |
|
Total
|
||||||||||
|
JPMorgan Facility
|
$
|
132,715
|
|
|
$
|
667,820
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
800,535
|
|
|
DB Repurchase Facility
|
131,419
|
|
|
191,807
|
|
|
—
|
|
|
—
|
|
|
323,226
|
|
|||||
|
Goldman Facility
|
—
|
|
|
103,025
|
|
|
—
|
|
|
—
|
|
|
103,025
|
|
|||||
|
Total
|
$
|
264,134
|
|
|
$
|
962,652
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,226,786
|
|
|
|
|
|
|
|
For the three months ended March 31, 2018
|
||||||||||
|
|
Balance at
March 31, 2018 |
|
Amortized Cost of Collateral at March 31, 2018
|
|
Maximum Month-End
Balance |
|
Average Month-End
Balance |
||||||||
|
JPMorgan Facility
|
$
|
800,535
|
|
|
$
|
1,372,877
|
|
|
$
|
914,040
|
|
|
$
|
786,087
|
|
|
DB Repurchase Facility
|
323,226
|
|
|
623,006
|
|
|
329,689
|
|
|
326,536
|
|
||||
|
Goldman Facility
|
103,025
|
|
|
180,243
|
|
|
103,025
|
|
|
87,312
|
|
||||
|
Total
|
$
|
1,226,786
|
|
|
$
|
2,176,126
|
|
|
|
|
|
||||
|
|
Principal Amount
|
Coupon Rate
|
Effective Rate
(1)
|
Conversion Rate
(2)
|
Maturity Date
|
Remaining Period of Amortization
|
|||||
|
2019 Notes
|
$
|
254,750
|
|
5.50
|
%
|
6.36
|
%
|
57.6745
|
|
3/15/2019
|
0.95 years
|
|
2022 Notes
|
345,000
|
|
4.75
|
%
|
5.61
|
%
|
50.2260
|
|
8/23/2022
|
4.40 years
|
|
|
Total
|
$
|
599,750
|
|
|
|
|
|
|
|||
|
(1)
|
Effective rate includes the effect of the adjustment for the conversion option (See endnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.
|
|
(2)
|
The Company has the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per
$1.0
million principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by the Company to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.
|
|
Type of Derivative
|
March 31, 2018
|
||||||
|
|
Number of Contracts
|
|
Aggregate Notional Amount (in thousands)
|
|
Notional Currency
|
|
Maturity
|
|
Fx Contracts - GBP
|
31
|
|
467,737
|
|
GBP
|
|
April 2018 - November 2020
|
|
Type of Derivative
|
December 31, 2017
|
||||||
|
|
Number of Contracts
|
|
Aggregate Notional Amount (in thousands)
|
|
Notional Currency
|
|
Maturity
|
|
Fx Contracts - GBP
|
24
|
|
177,077
|
|
GBP
|
|
January 2018- November 2020
|
|
|
|
|
Amount of gain (loss)
recognized in income
|
||||||
|
|
|
|
Three months ended March 31,
|
||||||
|
|
Location of (Gain) Loss Recognized in Income
|
|
2018
|
|
2017
|
||||
|
Forward currency contracts
|
Loss on derivative instruments - unrealized
|
|
$
|
(8,859
|
)
|
|
$
|
(2,883
|
)
|
|
Forward currency contracts
|
Loss on derivative instruments - realized
|
|
(2,177
|
)
|
|
(156
|
)
|
||
|
Interest rate caps
(1)
|
Gain (loss) on derivative instruments - unrealized
|
|
4
|
|
|
(6
|
)
|
||
|
Total
|
|
|
$
|
(11,032
|
)
|
|
$
|
(3,045
|
)
|
|
(1)
|
With a notional amount of
$38.9
million and
$44.2
million at
March 31, 2018
, and
2017
, respectively.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Gross
Amount of Recognized Liabilities |
|
Gross
Amounts Offset in the Condensed Consolidated Balance Sheet |
|
Net Amounts
of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet |
|
Gross
Amount of Recognized Liabilities |
|
Gross
Amounts Offset in the Consolidated Balance Sheet |
|
Net Amounts
of Liabilities Presented in the Consolidated Balance Sheet |
||||||||||||
|
Interest rate caps
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
1
|
|
|
Forward currency contracts
|
(18,777
|
)
|
|
4,273
|
|
|
(14,504
|
)
|
|
(5,645
|
)
|
|
—
|
|
|
(5,645
|
)
|
||||||
|
Total derivative instruments
|
$
|
(18,777
|
)
|
|
$
|
4,278
|
|
|
$
|
(14,499
|
)
|
|
$
|
(5,645
|
)
|
|
$
|
1
|
|
|
$
|
(5,644
|
)
|
|
|
March 31, 2018
|
|
|
December 31, 2017
|
|
||
|
Accrued dividends payable
|
$
|
63,598
|
|
|
$
|
56,576
|
|
|
Accrued interest payable
|
5,336
|
|
|
12,796
|
|
||
|
Accounts payable and other liabilities
|
4,396
|
|
|
1,534
|
|
||
|
Total
|
$
|
73,330
|
|
|
$
|
70,906
|
|
|
|
Type
|
|
Restricted Stock
|
|
RSUs
|
|
Grant Date Fair Value ($)
|
||
|
Outstanding at December 31, 2017
|
|
105,561
|
|
|
1,632,746
|
|
|
|
|
|
|
Vested
|
|
(2,749
|
)
|
|
—
|
|
|
n/a
|
|
Outstanding at March 31, 2018
|
|
102,812
|
|
|
1,632,746
|
|
|
|
|
|
Vesting Year
|
Restricted Stock
|
|
RSU
|
|
Total Awards
|
|||
|
2018
|
65,185
|
|
|
758,505
|
|
|
823,690
|
|
|
2019
|
32,733
|
|
|
569,909
|
|
|
602,642
|
|
|
2020
|
4,894
|
|
|
304,332
|
|
|
309,226
|
|
|
Total
|
102,812
|
|
|
1,632,746
|
|
|
1,735,558
|
|
|
Dividend declared per share of:
|
|
|
Common Stock
|
$0.46
|
|
Series B Preferred Stock
|
0.50
|
|
Series C Preferred Stock
|
0.50
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
Carrying
Value |
|
Estimated
Fair Value |
|
Carrying
Value |
|
Estimated
Fair Value |
||||||||
|
Cash
|
$
|
98,310
|
|
|
$
|
98,310
|
|
|
$
|
77,671
|
|
|
$
|
77,671
|
|
|
Commercial first mortgage loans, net
|
3,029,240
|
|
|
3,033,356
|
|
|
2,653,826
|
|
|
2,657,262
|
|
||||
|
Subordinate loans, net
|
1,038,254
|
|
|
1,035,838
|
|
|
1,025,932
|
|
|
1,029,390
|
|
||||
|
Secured debt arrangements
|
(1,226,786
|
)
|
|
(1,226,786
|
)
|
|
(1,345,195
|
)
|
|
(1,345,195
|
)
|
||||
|
2019 Notes
|
(252,270
|
)
|
|
(273,571
|
)
|
|
(251,935
|
)
|
|
(267,506
|
)
|
||||
|
2022 Notes
|
(333,342
|
)
|
|
(346,604
|
)
|
|
(332,962
|
)
|
|
(350,175
|
)
|
||||
|
|
For the three months ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
49,433
|
|
|
$
|
47,125
|
|
|
Preferred dividends
|
(6,835
|
)
|
|
(9,310
|
)
|
||
|
Net income available to common stockholders
|
42,598
|
|
|
37,815
|
|
||
|
Dividends declared on common stock
|
(56,577
|
)
|
|
(42,146
|
)
|
||
|
Dividends on participating securities
|
(751
|
)
|
|
(630
|
)
|
||
|
Net loss attributable to common stockholders
|
$
|
(14,730
|
)
|
|
$
|
(4,961
|
)
|
|
Denominator:
|
|
|
|
||||
|
Basic weighted average shares of common stock outstanding
|
110,211,853
|
|
|
91,612,447
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
111,871,429
|
|
|
92,998,250
|
|
||
|
Net income per weighted average share of common stock
|
|
|
|
||||
|
Distributable earnings per share of common stock
|
$
|
0.51
|
|
|
$
|
0.46
|
|
|
Undistributed loss per share of common stock
|
$
|
(0.13
|
)
|
|
$
|
(0.05
|
)
|
|
Net income per share of common stock
|
$
|
0.38
|
|
|
$
|
0.41
|
|
|
Description
|
|
Amortized
Cost |
|
Weighted Average Coupon
(1)
|
|
Weighted Average All-in Yield
(1)(2)
|
|
Secured Debt
(3)
|
|
Cost of Funds
|
|
Equity at
cost (4) |
|||||||||
|
Commercial mortgage loans, net
|
|
$
|
3,029,240
|
|
|
7.2
|
%
|
|
7.7
|
%
|
|
$
|
1,212,749
|
|
|
4.1
|
%
|
|
$
|
1,846,772
|
|
|
Subordinate loans, net
|
|
1,038,254
|
|
|
12.6
|
%
|
|
13.7
|
%
|
|
—
|
|
|
—
|
|
|
1,038,254
|
|
|||
|
Total/Weighted Average
|
|
$
|
4,067,494
|
|
|
8.6
|
%
|
|
9.2
|
%
|
|
$
|
1,212,749
|
|
|
4.1
|
%
|
|
$
|
2,885,026
|
|
|
(1)
|
Weighted-Average Coupon and Weighted Average All-in-Yield are based on the applicable benchmark rates as of March 31, 2018 on the floating rate loans.
|
|
(2)
|
Weighted-Average All-in-Yield includes the amortization of deferred origination fees, loan origination costs and accrual of both extension and exit fees.
|
|
(3)
|
Net of deferred financing costs of $14.0 million.
|
|
(4)
|
Represents loan portfolio at amortized cost plus loan proceeds held by servicer, less secured debt outstanding.
|
|
|
|
Average month-end balances for the three months ended March 31, 2018
|
||||||
|
Description
|
|
Assets
|
|
Related debt
|
||||
|
Commercial mortgage loans, net
|
|
$
|
2,771,662
|
|
|
$
|
1,199,935
|
|
|
Subordinate loans, net
|
|
1,033,771
|
|
|
—
|
|
||
|
|
Three months ended March 31,
|
|
2018 vs. 2017
|
||||||||
|
|
2018
|
|
2017
|
|
|
||||||
|
Net interest income:
|
|
|
|
|
|
||||||
|
Interest income from commercial mortgage loans
|
$
|
52,114
|
|
|
$
|
34,398
|
|
|
$
|
17,716
|
|
|
Interest income from subordinate loans
|
33,853
|
|
|
34,390
|
|
|
(537
|
)
|
|||
|
Interest income from securities
|
—
|
|
|
6,054
|
|
|
(6,054
|
)
|
|||
|
Interest expense
|
(22,740
|
)
|
|
(17,030
|
)
|
|
(5,710
|
)
|
|||
|
Net interest income
|
63,227
|
|
|
57,812
|
|
|
5,415
|
|
|||
|
Operating expenses:
|
|
|
|
|
|
||||||
|
General and administrative expenses
|
(4,998
|
)
|
|
(5,758
|
)
|
|
760
|
|
|||
|
Management fees to related party
|
(8,092
|
)
|
|
(7,432
|
)
|
|
(660
|
)
|
|||
|
Total operating expenses
|
(13,090
|
)
|
|
(13,190
|
)
|
|
100
|
|
|||
|
Income from unconsolidated joint venture
|
—
|
|
|
458
|
|
|
(458
|
)
|
|||
|
Other income
|
203
|
|
|
108
|
|
|
95
|
|
|||
|
Realized loss on sale of assets
|
—
|
|
|
(1,042
|
)
|
|
1,042
|
|
|||
|
Unrealized gain on securities
|
—
|
|
|
2,852
|
|
|
(2,852
|
)
|
|||
|
Foreign currency gain
|
10,125
|
|
|
3,172
|
|
|
6,953
|
|
|||
|
Loss on derivative instruments
|
(11,032
|
)
|
|
(3,045
|
)
|
|
(7,987
|
)
|
|||
|
Net income
|
$
|
49,433
|
|
|
$
|
47,125
|
|
|
$
|
2,308
|
|
|
Dividends declared per share of:
|
|
||
|
Common Stock
|
$
|
0.46
|
|
|
Series B Preferred Stock
|
0.50
|
|
|
|
Series C Preferred Stock
|
0.50
|
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
|
Debt-to-Equity Ratio
(1)
|
0.8x
|
|
0.9x
|
|
•
|
no investment will be made that would cause the Company to fail to qualify as a REIT for U.S. federal income tax purposes;
|
|
•
|
no investment will be made that would cause the Company to register as an investment company under the 1940 Act;
|
|
•
|
investments will be predominantly in the Company’s target assets;
|
|
•
|
no more than 20% of the Company’s cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment; and
|
|
•
|
until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with the Company’s intention to qualify as a REIT.
|
|
|
Less than 1
year (3) |
|
1 to 3
years (3) |
|
3 to 5
years (3) |
|
More
than 5 years |
|
Total
|
||||||||||
|
JPMorgan Facility
(1)
|
$
|
163,234
|
|
|
$
|
689,122
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
852,356
|
|
|
DB Repurchase Facility
(1)
|
199,300
|
|
|
147,904
|
|
|
—
|
|
|
—
|
|
|
347,204
|
|
|||||
|
Goldman Facility
(1)
|
9,764
|
|
|
102,988
|
|
|
—
|
|
|
—
|
|
|
112,752
|
|
|||||
|
Convertible Senior Notes
|
27,866
|
|
|
289,474
|
|
|
368,003
|
|
|
—
|
|
|
685,343
|
|
|||||
|
Unfunded loan commitments
(2)
|
338,851
|
|
|
513,657
|
|
|
—
|
|
|
—
|
|
|
852,508
|
|
|||||
|
Total
|
$
|
739,015
|
|
|
$
|
1,743,145
|
|
|
$
|
368,003
|
|
|
$
|
—
|
|
|
$
|
2,850,163
|
|
|
(1)
|
Based on the applicable benchmark rates as of March 31, 2018 on the floating rate debt for interest payments due under the JPMorgan Facility, the DB Repurchase Facility, and the Goldman Facility.
|
|
(2)
|
Based on the Company's expected funding schedule, which is based upon the Manager’s estimates based upon the best information available to the Manager at the time. There is no assurance that the payments will occur in accordance with these estimates or at all, which could affect the Company’s operating results.
|
|
(3)
|
Assumes
underlying assets are financed through the fully extended maturity date of the facility.
|
|
|
For the three months ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net income available to common stockholders
|
$
|
42,598
|
|
|
$
|
37,815
|
|
|
Adjustments:
|
|
|
|
||||
|
Equity-based compensation expense
|
3,342
|
|
|
3,791
|
|
||
|
Unrealized gain on securities
|
—
|
|
|
(2,852
|
)
|
||
|
Unrealized loss on derivative instruments
|
11,032
|
|
|
3,045
|
|
||
|
Foreign currency gain, net
|
(10,362
|
)
|
|
(3,326
|
)
|
||
|
Amortization of the convertible senior notes related to equity reclassification
|
1,140
|
|
|
608
|
|
||
|
Income from unconsolidated joint venture
|
—
|
|
|
(458
|
)
|
||
|
Total adjustments:
|
5,152
|
|
|
808
|
|
||
|
Operating Earnings
|
$
|
47,750
|
|
|
$
|
38,623
|
|
|
|
|
|
|
||||
|
Realized loss and costs from sale of CMBS
|
—
|
|
|
1,042
|
|
||
|
Operating Earnings excluding realized loss and costs from sale of CMBS
|
47,750
|
|
|
39,665
|
|
||
|
Basic and diluted Operating Earnings per share of common stock
|
$
|
0.43
|
|
|
$
|
0.41
|
|
|
Basic and diluted Operating Earnings excluding realized loss and costs from sale of CMBS per share of common stock
|
$
|
0.43
|
|
|
$
|
0.42
|
|
|
Basic weighted average shares of common stock outstanding
|
110,211,853
|
|
|
91,612,447
|
|
||
|
Diluted weighted average shares of common stock outstanding
|
111,871,429
|
|
|
92,998,250
|
|
||
|
•
|
attempting to structure its financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;
|
|
•
|
using hedging instruments, interest rate swaps and interest rate caps; and
|
|
•
|
to the extent available, using securitization financing to better match the maturity of the Company’s financing with the duration of its assets.
|
|
|
|
|
|
50 basis point increase
|
||||||||
|
Currency
|
|
Net floating rate assets subject to interest rate sensitivity
(1)
|
|
Increase to net interest income (in $)
(2)
|
|
Increase to net interest income (per Share)
(2)
|
||||||
|
USD
|
|
$
|
1,951,156
|
|
|
$
|
9,756
|
|
|
$
|
0.08
|
|
|
GBP
|
|
485,438
|
|
|
2,427
|
|
|
0.02
|
|
|||
|
Total:
|
|
$
|
2,436,594
|
|
|
$
|
12,183
|
|
|
$
|
0.10
|
|
|
3.1
|
|
|
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
3.3
|
|
|
|
|
|
|
|
3.4
|
|
|
|
|
|
|
|
4.1
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
|
4.3
|
|
|
|
|
|
|
|
4.4
|
|
|
|
|
|
|
|
4.5
|
|
|
|
|
|
|
|
4.6
|
|
|
|
|
|
|
|
31.1*
|
|
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
*
|
Filed herewith.
|
|
|
|
|
APOLLO COMMERCIAL REAL ESTATE FINANCE, INC.
|
|
|
|
|
|
|
May 2, 2018
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Stuart A. Rothstein
|
|
|
|
|
Stuart A. Rothstein
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jai Agarwal
|
|
|
|
|
Jai Agarwal
|
|
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|